The peptide cancer vaccine developed by Phylogica and the Telethon Kids Institute was described by Dr Hayes as a potentially ground breaking methodology. Why does Phylogica anticipate that its FPPs may play an important role in therapeutic cancer vaccines particularly noting that the global cancer vaccines market is forecast to grow to $7.5 billion in 2022?
Sources:
1. Comment by Dr Hayes - announcement January 8, 2018.
2. Relevance of progress - announcement January 31, 2018.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.035(2.72%) |
Mkt cap ! $729.0M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.25 | $4.615M | 3.649M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19481 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 9022 | 2 |
View Market Depth
| Last trade - 14.58pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |